Total Payments
$388,806
2024 Payments
$2,492
Companies
14
Transactions
221
Medicare Patients
223
Medicare Billing
$22,189
Payment Breakdown by Category
Consulting$229,727 (59.1%)
Travel$133,056 (34.2%)
Other$16,652 (4.3%)
Food & Beverage$4,244 (1.1%)
Research$3,966 (1.0%)
Education$1,162 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $229,727 | 49 | 59.1% |
| Travel and Lodging | $133,056 | 76 | 34.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,452 | 1 | 2.4% |
| Grant | $7,200 | 1 | 1.9% |
| Food and Beverage | $4,244 | 88 | 1.1% |
| Unspecified | $3,966 | 2 | 1.0% |
| Education | $1,162 | 4 | 0.3% |
Payments by Type
General
$384,840
219 transactions
Research
$3,966
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $272,476 | 146 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $36,442 | 27 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $17,985 | 3 | $0 (2020) |
| AstraZeneca AB | $15,134 | 22 | $0 (2021) |
| AstraZeneca UK Limited | $13,725 | 3 | $0 (2019) |
| Pulmonx Corporation | $10,245 | 8 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $9,452 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $5,143 | 2 | $0 (2021) |
| Genentech, Inc. | $3,951 | 3 | $0 (2023) |
| PneumRx, Inc | $3,824 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,492 | 3 | GlaxoSmithKline, LLC. ($1,625) |
| 2023 | $26,215 | 9 | GlaxoSmithKline, LLC. ($22,167) |
| 2021 | $7,757 | 4 | Novartis Pharmaceuticals Corporation ($5,143) |
| 2020 | $34,285 | 7 | Teva Pharmaceuticals USA, Inc. ($17,985) |
| 2019 | $92,490 | 60 | GlaxoSmithKline, LLC. ($60,865) |
| 2018 | $111,779 | 74 | GlaxoSmithKline, LLC. ($84,458) |
| 2017 | $113,788 | 64 | GlaxoSmithKline, LLC. ($88,087) |
All Payment Transactions
221 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/02/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,625.00 | General |
| 07/16/2024 | F. Hoffmann-La Roche AG | — | Consulting Fee | Cash or cash equivalent | $330.00 | General |
| 04/15/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $537.00 | General |
| 11/13/2023 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $2,600.00 | General |
| 11/12/2023 | Genentech, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,630.00 | General |
| 11/12/2023 | Genentech, Inc. | — | Travel and Lodging | Cash or cash equivalent | $243.21 | General |
| 11/12/2023 | Genentech, Inc. | — | Travel and Lodging | Cash or cash equivalent | $78.24 | General |
| 09/09/2023 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $18,498.66 | General |
| 09/09/2023 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $1,004.54 | General |
| 09/09/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $59.08 | General |
| 04/03/2023 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $96.94 | General |
| Category: PULMONOLOGY | ||||||
| 02/22/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), NUCALA | Food and Beverage | In-kind items and services | $4.49 | General |
| Category: RESPIRATORY | ||||||
| 09/07/2021 | Novartis Pharmaceuticals Corporation | — | — | In-kind items and services | $3,281.00 | Research |
| Study: PUBLICATION SUPPORT PROVIDED IN CONNECTION WITH RESEARCH AGREEMENT | ||||||
| 06/17/2021 | AstraZeneca AB | — | Consulting Fee | Cash or cash equivalent | $2,013.75 | General |
| 06/15/2021 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $1,862.00 | General |
| 05/19/2021 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR ENDOBRONCHIAL VALVE, ZEPHYR DELIVERY CATHETER | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: PULMONOLOGY | ||||||
| 12/09/2020 | Teva Pharmaceuticals USA, Inc. | AirDuo Digihaler (Drug) | Consulting Fee | Cash or cash equivalent | $4,087.50 | General |
| Category: Respiratory | ||||||
| 11/16/2020 | Teva Pharmaceuticals USA, Inc. | AirDuo Digihaler (Drug) | Consulting Fee | Cash or cash equivalent | $9,537.50 | General |
| Category: Respiratory | ||||||
| 10/19/2020 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $3,575.00 | General |
| 08/14/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Consulting Fee | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 07/06/2020 | Teva Pharmaceuticals USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,360.00 | General |
| 06/30/2020 | Pulmonx Corporation | Pulmonx Endobronchial Valve EBV (Device) | Education | Cash or cash equivalent | $1,025.25 | General |
| Category: Pulmonology | ||||||
| 02/24/2020 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $7,800.00 | General |
| 12/04/2019 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $796.59 | General |
| 12/04/2019 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $134.85 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PUBLICATION SUPPORT PROVIDED IN CONNECTION WITH RESEARCH AGREEMENT | Novartis Pharmaceuticals Corporation | $3,281 | 1 |
| A randomized, double blind, Sponsor open, placebo controlled, 52 week study evaluating the effect of danirixin GSK1325756 on lung function and health related quality of life in participants with mild to moderate Chronic Obstructive Pulmonary Disease CO | GlaxoSmithKline, LLC. | $685.10 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 17 | 24 | $5,904 | $1,458 |
| 2022 | 2 | 48 | 62 | $12,068 | $3,192 |
| 2021 | 4 | 72 | 83 | $14,934 | $4,567 |
| 2020 | 4 | 86 | 145 | $49,036 | $12,972 |
Total Patients
223
Total Services
314
Medicare Billing
$22,189
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 17 | 24 | $5,904 | $1,458 | 24.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 33 | 46 | $11,316 | $2,946 | 26.0% |
| 94618 | Test for exercise-induced lung stress | Facility | 2022 | 15 | 16 | $752.00 | $245.96 | 32.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 29 | 35 | $8,610 | $2,568 | 29.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 15 | 18 | $2,898 | $905.93 | 31.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 11 | 12 | $2,580 | $789.50 | 30.6% |
| 94618 | Test for exercise-induced lung stress | Facility | 2021 | 17 | 18 | $846.00 | $304.13 | 35.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 17 | 36 | $24,480 | $6,351 | 25.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 27 | 57 | $16,929 | $4,714 | 27.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 26 | 33 | $5,313 | $1,177 | 22.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 16 | 19 | $2,314 | $730.26 | 31.6% |
About Mark Dransfield
Mark Dransfield is a Critical Care Medicine healthcare provider based in Birmingham, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770526725.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mark Dransfield has received a total of $388,806 in payments from pharmaceutical and medical device companies, with $2,492 received in 2024. These payments were reported across 221 transactions from 14 companies. The most common payment nature is "Consulting Fee" ($229,727).
As a Medicare-enrolled provider, Dransfield has provided services to 223 Medicare beneficiaries, totaling 314 services with total Medicare billing of $22,189. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Location Birmingham, AL
- Active Since 06/14/2006
- Last Updated 02/01/2024
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1770526725
Products in Payments
- BEVESPI AEROSPHERE (Drug) $29,553
- TRELEGY ELLIPTA (Drug) $13,654
- AirDuo Digihaler (Drug) $13,625
- Pulmonx Endobronchial Valve EBV (Device) $9,548
- STIOLTO (Drug) $9,452
- FASENRA (Drug) $7,954
- ANORO (Drug) $5,870
- PNEUMRX COILS (Device) $3,897
- SYMBICORT (Drug) $3,112
- CHARTIS CATHETER (Device) $696.94
- BREO (Drug) $33.24
- Zemaira (Biological) $12.95
- DUPIXENT DUPILUMAB INJECTION (Biological) $12.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Birmingham
James Wells
Critical Care Medicine — Payments: $206,948
Critical Care Medicine $206,948
George Solomon
Critical Care Medicine — Payments: $109,602
Critical Care Medicine $109,602
Tracy Luckhardt
Critical Care Medicine — Payments: $51,348
Critical Care Medicine $51,348
Joseph Barney
Critical Care Medicine — Payments: $30,178
Critical Care Medicine $30,178
Peter Morris, Md, MD
Critical Care Medicine — Payments: $22,246
Critical Care Medicine $22,246
Erin Ozgun, M.d, M.D
Critical Care Medicine — Payments: $15,945
Critical Care Medicine $15,945